Home
About
Publications Trends
Recent Publications
Expert Search
Archive
log rank test
How Can Violations of Assumptions be Addressed?
If the proportional hazards assumption is violated, alternative methods such as the
Cox proportional hazards model
or the use of time-dependent covariates can be employed. Sensitivity analyses can also be conducted to assess the impact of censoring.
Frequently asked queries:
Why is the Log Rank Test Important in Cancer Research?
How is the Log Rank Test Conducted?
What are the Assumptions of the Log Rank Test?
What are the Advantages of the Log Rank Test?
What are the Limitations of the Log Rank Test?
How Can Violations of Assumptions be Addressed?
What Conditions Do They Treat?
How Does Interoperability Improve Patient Outcomes?
Can Cancer Patients Safely Receive Epidural or Spinal Anesthesia?
What Are the Challenges in Targeting EGFR Amplification?
What Treatments Target Cancer Cells?
Which Types of Cancer Can Kale Help Prevent?
What is the Prognosis for Cancer Patients with Dysarthria?
What Are the Key Issues in Cancer Advocacy?
How Do Cancer Care Facilities Support Survivors?
Are There Risks Associated with Soy Consumption?
What are Some Examples of Cancer Audit Criteria?
What Are the Benefits of Online Communities?
What is the Role of Screening in Cancer Risk Management?
How Do Opioids Work in Pain Management?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe